NEW YORK — A U.S. biotech company says it plans to start this summer the world’s first study of a treatment based on human embryonic stem cells — a long-awaited project aimed at spinal cord injury.
DISCLAIMER: Catholic Answers has turned over the archive to Catholic-Questions.org and no longer owns, manages, or moderates the forums. For additional apologetics resources please visit www.catholic.com.
